Advertisement

Global Mental Health and Psychopharmacology in Precarious Ecologies: Anthropological Considerations for Engagement and Efficacy

  • Janis H. Jenkins
  • Ellen Kozelka
Chapter

Abstract

Contrary to common assumptions, treatments that use psychopharmaceuticals require thorough cultural consideration just as psychosocial interventions do. Current efforts to “scale up” global mental health interventions must recognize the social, cultural, and psychological contexts of mental illness and its treatment, and the ecological features of environments with respect to socioeconomic and political conditions that may predispose persons to mental illness through entrapment in precarious situations. Such interventions should be based on a fine-tuned engagement with patients and their families characterized by engaged listening and dialogue if they are to facilitate communication and understanding of both the medical and social expectations associated with the use of psychopharmaceuticals.

Keywords

Mental Health Mental Illness Mental Health Service Subjective Experience Psychotropic Medication 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Basu, H. (2014). Davaa and Duaa: The pluralization of healing mental disorders at a Muslim pilgrimage centre. In W. Sax, H. Naraindas, & J. Quack (Eds.), Asymmetrical conversations—Contestations, circumventions and the blurring of therapeutic boundaries (pp. 162–199). Oxford: Berghahn Books.Google Scholar
  2. Biehl, J., Good, B. J., & Kleinman, A. (Eds.). (2007). Subjectivity: Ethnographic investigations. Berkeley: University of California Press.Google Scholar
  3. Breslau, J. (2004). Cultures of trauma: Anthropological views of posttraumatic stress disorders in international health. Culture, Medicine and Psychiatry, 28(2), 113–126.CrossRefPubMedGoogle Scholar
  4. Brown, G. W., Andrews, B., Harris, T., Adler, Z., & Bridge, L. (1986). Social support, self-esteem, and depression. Psychological Medicine, 16, 813–831.CrossRefPubMedGoogle Scholar
  5. de Jesus, M. J., Razzouk, D., Thara, R., Eaton, J., & Thornicroft, G. (2009). Packages of care for schizophrenia in low- and middle-income countries. PLoS Med, 6(10), e1000165. doi: 10.1371/journal.pmed.1000165.CrossRefPubMedGoogle Scholar
  6. Dumit, J. (2012). Drugs for life: How pharmaceutical companies define our health. Durham: Duke University Press.CrossRefGoogle Scholar
  7. Duncan, W. L. (2012). The culture of mental health in a changing Oaxaca. PhD dissertation, University of California, San Diego.Google Scholar
  8. Eaton, J., McCay, L., Semrau, M., Chatterjee, S., Baingana, F., Araya, R., et al. (2011). Scale up of services for mental health in low-income and middle-income countries. The Lancet, 378(9802), 1592–1603. doi: 10.1016/S0140-6736(11)60891-X.CrossRefGoogle Scholar
  9. Ecks, S. (2013). Eating drugs: Psychopharmaceutical pluralism in India. New York: New York University Press.CrossRefGoogle Scholar
  10. Ecks, S., & Basu, S. (2009). The unlicensed lives of antidepressants in India: Generic drugs, unqualified practitioners, and floating prescriptions. Transcultual Psychiatry, 46(1), 86–106. doi: 10.1177/1363461509102289.CrossRefGoogle Scholar
  11. Farmer, P. (2004). An anthropology of structural violence. Current Anthropology, 45(3), 305–325.CrossRefGoogle Scholar
  12. Farmer, P. (2015). Who lives and who dies. London Review of Books, 37(3), 17–20.Google Scholar
  13. Good, B. (2010). Medical anthropology and the problem of belief. In B. J. Good, M. M. J. Fischer, S. S. Willen, & M.-J. DelVecchio Good (Eds.), A reader in medical anthropology: Theoretical trajectories, emergent realities (pp. 64–76). New York: Wiley-Blackwell.Google Scholar
  14. Good, B., DelVecchio Good, M.-J., & Grayman, J. (2014). Is PTSD a “good enough” concept for post-conflict mental helath work? In D. Hinton & B. J. Good (Eds.), Reflection on work in Aceh, Indonesia. In culture and PTSD. Philadelphia: University of Pennsylvannia Press.Google Scholar
  15. Hinton, L., Aggarwal, N., Iosif, A. M., Weiss, M., Paralikar, V., Deshpande, S., et al. (2015). Perspectives of family members participating in cultural assessment of psychiatric disorders: Findings from the DSM-5 international field trial. International Review of Psychiatry, 27(1), 3–10.CrossRefPubMedCentralPubMedGoogle Scholar
  16. How, S. K. H., Fryer, A.-K., McCarthy, D., Schoen, C., & Schor, E. L. (2011). Securing a healthy future: The commonwealth fund state scorecard on child health system performance. New York: Commonwealth Fund.Google Scholar
  17. Institute of Medicine. (2013). U.S. health in international perspective: Shorter lives, poorer health. Report Brief (January), 1–4. Retrieved from http://iom.edu/~/media/Files/Report%20Files/2013/US-Health-International-Perspective/USHealth_Intl_PerspectiveRB.pdf
  18. Jain, S., & Jadhav, S. (2009). Pills that swallow policy: Clinical ethnography of a community mental health program in Northern India. Transcultural Psychiatry, 46(1), 60–85.CrossRefPubMedGoogle Scholar
  19. Jenkins, J. H. (1991). The state construction of affect: Political ethos and mental health among Salvadoran refugees. Culture, Medicine, and Psychiatry, 15, 139–165.CrossRefGoogle Scholar
  20. Jenkins, J. H. (Ed.). (2010). Pharmaceutical self: The global shaping of experience in an age of psychopharmacology. Santa Fe: School of Advanced Research Press.Google Scholar
  21. Jenkins, J. H. (2015a). Extraordinary conditions: Culture and experience in mental illness. Berkeley: University of California Press.Google Scholar
  22. Jenkins, J. H. (2015b). Straining psychic and social sinew: Trauma among adolescent psychiatric patients in New Mexico. Medical Anthropology Quarterly, 29, 42–60. doi: 10.1111/maq.12104.CrossRefPubMedGoogle Scholar
  23. Jenkins, J. H., & Barrett, R. J. (Eds.). (2004). Schizophrenia, culture, and subjectivity: The edge of experience. Cambridge: Cambridge University Press.Google Scholar
  24. Jenkins, J. H., & Carpenter-Song, E. (2005). The new paradigm of recovery from schizophrenia: Cultural conundrums of improvement without cure. Culture Medicine and Psychiatry, 29(4), 379–413. doi: 10.1007/s11013-006-9000-8.CrossRefGoogle Scholar
  25. Jenkins, J. H., & Carpenter-Song, E. (2008). Stigma despite recovery: Strategies for living in the aftermath of psychosis. Medical Anthropology Quarterly, 22(4), 381–409.CrossRefPubMedGoogle Scholar
  26. Jenkins, J. H., & DelVecchio Good, M.-J. (2014). Women and global mental health: Vulnerability and empowerment. In S. O. Opakpu (Ed.), Essentials of global mental health. Cambridge: Cambridge University Press.Google Scholar
  27. Jenkins, J. H., & Karno, M. (1992). The meaning of “expressed emotion”: Theoretical issues raised by cross-cultural research. American Journal of Psychiatry, 149, 9–21.CrossRefPubMedGoogle Scholar
  28. Kienzler, H., & Pedersen, D. (2012). Strange but common bedfellows: The relationship between humanitarians and the military in developing psychosocial interventions for civilian populations affected by armed conflict. Transcultual Psychiatry, 49(3–4), 492–518. doi: 10.1177/1363461512447927.CrossRefGoogle Scholar
  29. Kim, J. Y., Farmer, P., & Porter, M. E. (2013). Redefining global health-care delivery. The Lancet, 382(9897), 1060–1069.CrossRefGoogle Scholar
  30. Kleinman, A. (1986). Social origins of distress and disease: Depression, neurasthenia, and pain in modern China. New Haven: Yale University Press.Google Scholar
  31. Kleinman, A. (1988). Rethinking psychiatry. New York: Free Press.Google Scholar
  32. Kleinman, A., & Kleinman, J. (1997). The appeal of experience, the dismay of images: Cultural appropriations of suffering in our times. In A. Kleinman, V. Das, & M. Lock (Eds.), Social suffering (pp. 1–24). Berkeley: University of California Press.Google Scholar
  33. Kohrt, B., Johnson, M. J. D., Tol, W. A., Speckman, R. A., Maharjan, S. M., Worthman, C. M., & Komproe, I. H. (2015). Comparison of mental health between former child soldiers and children never conscripted by armed groups in Nepal. Journal of the American Medical Association, 300, 691–702.CrossRefGoogle Scholar
  34. Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., et al. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. The New England Journal of Medicine, 353, 1209–1223.CrossRefPubMedGoogle Scholar
  35. Martínez, H. A. (2000). What’s behind the symptom? On psychiatric observation and anthropological understanding. New York: Taylor & Francis.Google Scholar
  36. Mensah, E. S., & Yeboah, F. A. (2003). A preliminary study into the evaluation of drug compliance among psychiatric patients in Komfo Anokye Teaching Hospital, Ghana. Ghana Medical Journal, 37, 68–71.Google Scholar
  37. Metzl, J. M., & Hansen, H. (2014). Structural competency: Theorizing a new medical engagement with stigma and inequality. Social Science & Medicine, 103, 126–133.CrossRefGoogle Scholar
  38. Office of the Surgeon General (US) & Center for Mental Health Services (US). (2001). Mental health: Culture, race, and ethnicity: A supplement to mental health: A report of the surgeon general. Rockville, MD: Substance Abuse and Mental Health Services Administration. Retrieved from http://www.ncbi.nlm.nih.gov/books/NBK44243/
  39. Parish, S. M. (2008). Subjectivity and suffering in American culture. New York: Palgrave Macmillan.CrossRefGoogle Scholar
  40. Patel, V. (2014). Why mental health matters to global health. Transcultural psychiatry, 51(6), 777–789.CrossRefPubMedGoogle Scholar
  41. Patel, V., Araya, R., Chatterjee, S., Chisholm, D., Cohen, A., De Silva, M., et al. (2007). Treatment and prevention of mental disorders in low-income and middle-income countries. The Lancet, 370(9591), 991–1005.CrossRefGoogle Scholar
  42. Patel, V., Simon, G., Chowdhary, N., Kaaya, S., & Araya, R. (2009). Packages of care for depression in low-and middle-income countries. PLoS Med, 6(10), e1000159.CrossRefPubMedCentralPubMedGoogle Scholar
  43. Pupavac, V. (2002). Pathologizing populations and colonizing minds: International psychosocial programs in Kosovo. Alternatives, 27, 489–511.Google Scholar
  44. Read, U. (2012). “I want the one that will heal me completely so it won’t come back again”: The limits of antipsychotic medication in rural Ghana. Transcultural Psychiatry, 49(3–4), 438–460.CrossRefPubMedGoogle Scholar
  45. Summerfield, D. (2004). Cross-cultural perspectives on the medicalization of human suffering. In G. M. Rosen (Ed.), Posttraumatic stress disorder: Issues and controversies. Chichester: John Wiley & Sons Ltd.Google Scholar
  46. Summerfield, D. (2012). Afterword: Against global mental health. Transcultural Psychiatry, 49(3), 519.CrossRefPubMedGoogle Scholar
  47. Van der Geest, S., Whyte, S. R., & Hardon, A. (1996). The anthropology of pharmaceuticals: A biographical approach. Annual Review of Anthropology, 25, 153–178.CrossRefGoogle Scholar
  48. Whyte, S. R. (1991). Family experiences with mental health problems in Tanzania. Acta Psychiatrica Scandinavica, 83(S364), 77–111.CrossRefGoogle Scholar
  49. Whyte, S. R., Van der Geest, S., & Hardon, A. (2002). Social lives of medicines. Cambridge University Press.Google Scholar
  50. Woods, A., Romme, M., McCarthy-Jones, S., Escher, S., & Dillon, J. (2013). Special edition: Voices in a positive light. Psychosis, 5(3), 213–215.CrossRefGoogle Scholar
  51. World Health Organization. (2005). Mental health policy and service guidance package: Improving access and use of psychotropic medicines. Geneva, Switzerland: World Health Organization.Google Scholar
  52. World Health Organization. (2014). Social determinants of mental health. Geneva, Switzerland: World Health Organization.Google Scholar

Copyright information

© The Author(s) 2017

Authors and Affiliations

  • Janis H. Jenkins
    • 1
  • Ellen Kozelka
    • 1
  1. 1.Department of Anthropology and PsychiatryUniversity of CaliforniaSan Diego, CAUSA

Personalised recommendations